🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.20.10033 Boehringer Ingelheim Investigational Site
Start Date
2008-02
Trial ID
NCT00622284
The objective of the study is to test the efficacy, safety and tolerability...
Status
Completed
Location
1218.6.3302A Boehringer Ingelheim Investigational Site
Start Date
2006-04
Trial ID
NCT00309608
Treatments Being Tested
The purpose of this research study is to evaluate the efficacy and safety o...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2018-03-20
Trial ID
NCT03429543
Treatments Being Tested
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.18.54001 Boehringer Ingelheim Investigational Site
Start Date
2008-02
Trial ID
NCT00602472
Treatments Being Tested
This study will test the effect of four common oral anti-diabetic agents on...
Status
Unknown
Location
Oslo University Hospital, Aker Hospital
Start Date
2021-02-10
Trial ID
NCT04662866
The purpose of this study is to assess the efficacy of HSK7653 (as an add-o...
Status
Completed
Location
Peking University People's Hospital
Start Date
2020-11-13
Trial ID
NCT04564872
Treatments Being Tested
Investigators propose to examine the effect of 12 weeks of Linagliptin, a d...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2013-10
Trial ID
NCT01969084
Treatments Being Tested
To evaluate the efficacy and safety of linagliptin compared to placebo when...
Status
Completed
Location
China-Japan Friendship Hospital
Start Date
2016-09-30
Trial ID
NCT02897349
Treatments Being Tested
To investigate the efficacy, safety, and tolerability of linagliptin 5 mill...
Status
Completed
Location
Syed Research Consultants, LLC
Start Date
2014-09-23
Trial ID
NCT02240680
Treatments Being Tested
to determine safety, efficacy and tolerability of BI 1356 versus placebo...
Status
Completed
Location
1218.43.10027 Boehringer Ingelheim Investigational Site
Start Date
2008-12
Trial ID
NCT00800683